Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark M Awad

Showing results (21-30 of 210) with videos related to

Pageof 21
Sort By:
Clinical Nuclear Medicine|November 5, 2021
Radiation Recall Pneumonitis on FDG PET/CT Triggered by COVID-19 VaccinationNicola M Hughes, Mark M Hammer, Mark M Awad, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 29, 2018
Authors' ResponseMatthew P Cheng, Francisco M Marty, Daniel B Costa, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 2, 2014
Successful desensitization of two patients with ALK-positive lung cancer and hypersensitivity to crizotinibMark M Awad, Timothy P Lax, Benjamin R Slawski, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 10, 2021
Axillary Lymphadenopathy After Coronavirus Disease 2019 Vaccinations in Patients With Thoracic Malignancy: Incidence, Predisposing Factors, and Imaging CharacteristicsMizuki Nishino, Hiroto Hatabu, Biagio Ricciuti, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 10, 2018
An Acquired NRAS Q61K Mutation in BRAF V600E-Mutant Lung Adenocarcinoma Resistant to Dabrafenib Plus TrametinibDaniel L Abravanel, Mizuki Nishino, Lynette M Sholl, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 20, 2023
Letter to the Editor: Reply to Zhao, Wu, and MaJoao V Alessi, Arielle Elkrief, Biagio Ricciuti, et al.
JTO Clinical and Research Reports|September 30, 2021
<i>BRAF</i>-Mutant Pulmonary Langerhans Cell Histiocytosis Mimicking Recurrence of Early-Stage <i>KRAS</i>-Mutant Lung AdenocarcinomaStephanie L Alden, Scott J Swanson, Mizuki Nishino, et al.
European Journal of Radiology|September 19, 2020
Immune-related adverse events on body CT in patients with small-cell lung cancer treated with immune-checkpoint inhibitorsHyesun Park, Hiroto Hatabu, Biagio Ricciuti, et al.
Radiology|October 25, 2022
Molecular Characterization and Therapeutic Approaches to Small Cell Lung Cancer: Imaging ImplicationsHyesun Park, Shu-Chi Tseng, Lynette M Sholl, et al.
Cancer Immunology, Immunotherapy : CII|March 17, 2019
Pre-existing autoimmune disease and the risk of immune-related adverse events among patients receiving checkpoint inhibitors for cancerKenneth L Kehl, Shihao Yang, Mark M Awad, et al.
Pageof 21

Showing results (21-30 of 210) with videos related to

Sort By:
Pageof 21
Clinical Nuclear Medicine|November 5, 2021
Radiation Recall Pneumonitis on FDG PET/CT Triggered by COVID-19 VaccinationNicola M Hughes, Mark M Hammer, Mark M Awad, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 29, 2018
Authors' ResponseMatthew P Cheng, Francisco M Marty, Daniel B Costa, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 2, 2014
Successful desensitization of two patients with ALK-positive lung cancer and hypersensitivity to crizotinibMark M Awad, Timothy P Lax, Benjamin R Slawski, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 10, 2021
Axillary Lymphadenopathy After Coronavirus Disease 2019 Vaccinations in Patients With Thoracic Malignancy: Incidence, Predisposing Factors, and Imaging CharacteristicsMizuki Nishino, Hiroto Hatabu, Biagio Ricciuti, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 10, 2018
An Acquired NRAS Q61K Mutation in BRAF V600E-Mutant Lung Adenocarcinoma Resistant to Dabrafenib Plus TrametinibDaniel L Abravanel, Mizuki Nishino, Lynette M Sholl, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 20, 2023
Letter to the Editor: Reply to Zhao, Wu, and MaJoao V Alessi, Arielle Elkrief, Biagio Ricciuti, et al.
JTO Clinical and Research Reports|September 30, 2021
<i>BRAF</i>-Mutant Pulmonary Langerhans Cell Histiocytosis Mimicking Recurrence of Early-Stage <i>KRAS</i>-Mutant Lung AdenocarcinomaStephanie L Alden, Scott J Swanson, Mizuki Nishino, et al.
European Journal of Radiology|September 19, 2020
Immune-related adverse events on body CT in patients with small-cell lung cancer treated with immune-checkpoint inhibitorsHyesun Park, Hiroto Hatabu, Biagio Ricciuti, et al.
Radiology|October 25, 2022
Molecular Characterization and Therapeutic Approaches to Small Cell Lung Cancer: Imaging ImplicationsHyesun Park, Shu-Chi Tseng, Lynette M Sholl, et al.
Cancer Immunology, Immunotherapy : CII|March 17, 2019
Pre-existing autoimmune disease and the risk of immune-related adverse events among patients receiving checkpoint inhibitors for cancerKenneth L Kehl, Shihao Yang, Mark M Awad, et al.
Pageof 21